Variant report
Variant | nsv550973 |
---|---|
Chromosome Location | chr10:56441751-56469288 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2384520 | chr10:56441751-56441752 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs78217146 | chr10:56441752-56441753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184795172 | chr10:56441794-56441795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374335656 | chr10:56441801-56441802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148615166 | chr10:56441862-56441863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76689959 | chr10:56441948-56441949 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs398013521 | chr10:56441955-56441956 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538050999 | chr10:56442115-56442116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs367873405 | chr10:56442118-56442119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554420577 | chr10:56442124-56442125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188463105 | chr10:56442133-56442134 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192687074 | chr10:56442172-56442173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs199586033 | chr10:56442210-56442211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142044817 | chr10:56442235-56442236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572899846 | chr10:56442240-56442241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545418410 | chr10:56442271-56442272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556987794 | chr10:56442282-56442283 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565582022 | chr10:56442337-56442338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371147521 | chr10:56442399-56442400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550093423 | chr10:56442428-56442429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567326891 | chr10:56442461-56442462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs115465839 | chr10:56442499-56442500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534756658 | chr10:56442604-56442605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529851352 | chr10:56442729-56442730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546695124 | chr10:56442779-56442780 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553092722 | chr10:56442803-56442804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532122031 | chr10:56442846-56442847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs551844679 | chr10:56442850-56442851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184464441 | chr10:56442890-56442891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537720897 | chr10:56442895-56442896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570114500 | chr10:56442940-56442941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112162973 | chr10:56442952-56442953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554357792 | chr10:56443016-56443017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs1336200 | chr10:56443025-56443026 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs150745528 | chr10:56443029-56443030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370777035 | chr10:56443036-56443037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188861242 | chr10:56443063-56443064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34001428 | chr10:56443072-56443073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181956298 | chr10:56443107-56443108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558654281 | chr10:56443156-56443157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs367762957 | chr10:56443165-56443166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575912337 | chr10:56443184-56443185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113193968 | chr10:56443204-56443205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557929734 | chr10:56443218-56443219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544564137 | chr10:56443226-56443227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561496103 | chr10:56443258-56443259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372473169 | chr10:56443262-56443263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs117741188 | chr10:56443269-56443270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560296513 | chr10:56443279-56443280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184579795 | chr10:56443282-56443283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56441400-56442800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr10:56441600-56441800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr10:56441800-56442400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr10:56442400-56442600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr10:56442600-56443000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr10:56443000-56443400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr10:56448600-56449000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr10:56449000-56451000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
9 | chr10:56450200-56452800 | Enhancers | Fetal Lung | lung |
10 | chr10:56450800-56451600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr10:56451000-56451600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr10:56451200-56451600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr10:56458000-56459000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr10:56466400-56471000 | Enhancers | Fetal Lung | lung |
15 | chr10:56466600-56469000 | Enhancers | Fetal Brain Male | brain |
16 | chr10:56467600-56468800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
17 | chr10:56468600-56469200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr10:56469200-56470600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |